197 results on '"van Faassen, Henk"'
Search Results
2. Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22
3. Supplementary Figure S4 from Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6
4. Data from Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6
5. Supplementary Data from Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6
6. Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models
7. A Novel Antigen Design Strategy to Isolate Single‐Domain Antibodies that Target Human Nav1.7 and Reduce Pain in Animal Models.
8. Correction to: Llama peripheral B-cell populations producing conventional and heavy chain-only IgG subtypes are phenotypically indistinguishable but immunogenetically distinct
9. Facile Affinity Maturation of Single-Domain Antibodies Using Next-Generation DNA Sequencing
10. Discovery and Pre-Clinical Development of a Therapeutically Active Nanobody-based Chimeric Antigen Receptor targeting human CD22
11. Defining the epitope of a blood–brain barrier crossing single domain antibody specific for the type 1 insulin-like growth factor receptor
12. Llama peripheral B-cell populations producing conventional and heavy chain-only IgG subtypes are phenotypically indistinguishable but immunogenetically distinct
13. Targeting Novel LPXTG Surface Proteins with Monoclonal Antibodies for Immunomagnetic Separation of Listeria monocytogenes
14. Corrigendum: Structure-guided design of a potent Clostridioides difficile toxin A inhibitor
15. Epitope mapping of a blood-brain barrier crossing antibody targeting the cysteine-rich region of IGF1R using hydrogen-exchange mass spectrometry enabled by electrochemical reduction
16. Structure-guided design of a potent Clostridiodes difficile toxin A inhibitor
17. HSV-1 Oncolytic Virus Targeting CEACAM6-Expressing Tumors Using a Bispecific T-Cell Engager
18. Epitope mapping of a blood–brain barrier crossing antibody targeting the cysteine-rich region of IGF1R using hydrogen-exchange mass spectrometry enabled by electrochemical reduction
19. Brain Delivery of IGF1R5, a Single-Domain Antibody Targeting Insulin-like Growth Factor-1 Receptor
20. Structural Characterization and Evaluation of an Epitope at the Tip of the A-Band Rhamnan Polysaccharide of Pseudomonas aeruginosa
21. Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease
22. Specificity analysis of the C-type lectin from rattlesnake venom, and its selectivity towards Gal- or GalNAc-terminated glycoproteins
23. Protease-resistant single-domain antibodies inhibit Campylobacter jejuni motility
24. Antibody light chain variable domains and their biophysically improved versions for human immunotherapy
25. Incorporation of a Novel CD16-Specific Single-Domain Antibody into Multispecific Natural Killer Cell Engagers With Potent ADCC
26. Development and Characterization of Mouse Monoclonal Antibodies Specific for Clostridiodes (Clostridium) difficile Lipoteichoic Acid
27. Hydrogen-deuterium exchange mass spectrometry reveals three unique binding responses of mAbs directed to the catalytic domain of hCAIX
28. Targeting insulin‐like growth factor‐1 receptor (IGF1R) for brain delivery of biologics.
29. Disulfide linkage engineering for improving biophysical properties of human VH domains 6
30. A VL single-domain antibody library shows a high-propensity to yield non-aggregating binders †
31. Serum albumin‐binding V H Hs with variable pH sensitivities enable tailored half‐life extension of biologics
32. Development and Characterization of Mouse Monoclonal Antibodies Specific for Clostridiodes (Clostridium) difficile Lipoteichoic Acid
33. The human fumarylacetoacetase gene: characterisation of restriction fragment length polymorphisms and identification of haplotypes in tyrosinemia type 1 and pseudodeficiency
34. Camelid single-domain antibodies raised by DNA immunization are potent inhibitors of EGFR signaling
35. Neutralization of Clostridium difficile toxin B with VHH-Fc fusions targeting the delivery and CROPs domains
36. Serum albumin‐binding VHHs with variable pH sensitivities enable tailored half‐life extension of biologics.
37. A Novel Affinity Tag, ABTAG, and Its Application to the Affinity Screening of Single-Domain Antibodies Selected by Phage Display
38. A disulfide-stabilized human V L single-domain antibody library is a source of soluble and highly thermostable binders
39. Development and Characterization of Mouse Monoclonal Antibodies Specific for Clostridiodes (Clostridium) difficileLipoteichoic Acid
40. Neutralization of Clostridium difficile toxin B with VHH-Fc fusions targeting the delivery and CROPs domains.
41. Molecular Basis for Recognition of the Cancer Glycobiomarker, LacdiNAc (GalNAc[β1→4]GlcNAc), by Wisteria floribunda Agglutinin
42. A Rational Engineering Strategy for Designing Protein A-Binding Camelid Single-Domain Antibodies
43. High affinity anti-Internalin B VHH antibody fragments isolated from naturally and artificially immunized repertoires
44. Pathogen Proliferation Governs the Magnitude but Compromises the Function of CD8 T Cells1
45. Pentavalent Single-Domain Antibodies Reduce Campylobacter jejuni Motility and Colonization in Chickens
46. Antibody light chain variable domains and their biophysically improved versions for human immunotherapy
47. Monoclonal Antibodies Recognizing the Surface Autolysin IspC of Listeria monocytogenes Serotype 4b: Epitope Localization, Kinetic Characterization, and Cross-Reaction Studies
48. Neutralization of Clostridium difficile Toxin A with Single-domain Antibodies Targeting the Cell Receptor Binding Domain
49. Crystallization and preliminary X-ray diffraction studies of the lepidopteran-specific insecticidal crystal protein CrylA(a)
50. Single-Domain Antibody-Nanoparticles: Promising Architectures for Increased Staphylococcus aureus Detection Specificity and Sensitivity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.